Hawaiian Eye & Retina Meeting

Retina Program

CME BREAKFAST SEMINAR

6:30 am – 7:30 am

Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-term Outcomes

  • This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
7:30 am – 7:45 am

Break

CME GENERAL SESSIONS

The Changing Ophthalmic Practice Environment
  • Moderators: Patti Barkey, COE; Allison W. Shuren, MSN, JD
7:45 am – 7:50 am

Welcome

  • Patti Barkey, COE
7:50 am – 8:20 am

The Survivor Mentality

  • Craig N. Piso, PhD
8:20 am – 9:15 am

Panel Discussion: How We Survived and What Positive Changes Have Come Out of Our Experiences

  • Moderators: Patti Barkey, COE; Craig N. Piso, PhD
    Panelists: Kirk Mack, COMT, COE, CPC, CPMA; Allison W. Shuren, MSN, JD; William B. Trattler, MD
9:15 am – 9:45 am

NETWORKING & REFRESHMENTS IN THE EXHIBIT HALL

9:45 am – 10:45 am

What’s New for 2021?

10:45 am – 11:15 am

Healthcare Law in the New Normal: What Just happened? Telehealth View, Human Resources Post-COVID-19, Physician Contracting and How Salary Addendums were Handled

  • Allison W. Shuren, MSN, JD
11:15 am – 12:15 pm

Work Smarter Not Harder: The Team Approach Using Staff and Technology at the Highest Level

  • Moderator: Patti Barkey, COE
    Panelists: Carrie Jacobs, COE; Candace S. Simerson, FASOA, COE, CMPE; Savak “Sev” Teymoorian, MD, MBA
12:15 pm – 12:30 pm

Break

CME LUNCH SEMINAR

12:30 pm – 1:30 pm

Educational Program & Lunch

AFTERNOON PROGRAM**

1:30 pm – 3:00 pm

Disruptive Innovations Symposium: New Technology IOLs, Diagnostics and Drug Delivery

  • Moderators: Neda Shamie, MD; William B. Trattler, MD
    Panelists: John A. Hovanesian, MD, FACS; Marguerite B. McDonald, MD, FACS; Vance M. Thompson, MD, FACS; Elizabeth Yeu, MD
    This session is sponsored by Johnson & Johnson Vision
  • **This session is not approved for CME/CNE/COE Credit(s) and is neither provided by nor endorsed by Hawaiian Eye/Retina 2021 or their accredited provider.

INDUSTRY EXPERT THEATER BREAKFAST**

6:30 am – 7:30 am

Educational Program & Breakfast

  • **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2021 or its accredited provider.
7:30 am – 7:45 am

Break

CME GENERAL SESSIONS

Update on Imaging and New Technologies
  • Moderator: Judy E. Kim, MD
7:45 am – 7:49 am

Welcome & Announcements

  • Judy E. Kim, MD
7:50 am – 8:06 am

Mechanisms in the Development and Progression of ERM using Advanced Imaging

  • David Sarraf, MD
8:07 am – 8:23 am

Challenges in Tele-retinal Screening for Diabetic Retinopathy

  • Christina Y. Weng, MD, MBA
8:24 am – 8:40 am

Using Imaging to Improve Your Uveitis Game

  • Yasha S. Modi, MD
8:41 am – 8:57 am

An Update on OCT and Imaging in the Home

  • Nancy M. Holekamp, MD
8:58 am – 9:14 am

Tele-retina in the Management of AMD and Retinal Vascular Diseases

  • Sophie J. Bakri, MD
9:15 am – 9:45 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

New Treatments for Retinal Vascular Disease
  • Moderator: Peter K. Kaiser, MD
    Panelists: Sophie J. Bakri, MD; Caroline R. Baumal, MD; Nancy M. Holekamp, MD; Carl D. Regillo, MD, FACS; Christina Y. Weng, MD, MBA
9:45 am – 9:55 am

Plasmin Kallikrein Inhibition

  • Peter K. Kaiser, MD
9:55 am – 10:00 am

Discussion

10:00 am – 10:10 am

TIE2, Integrin, and VEGF Pathways and Retinal Diseases

  • Peter K. Kaiser, MD
10:10 am – 10:15 am

Discussion

10:15 am – 10:25 am

Biosimilars and Retinal Diseases

  • Peter K. Kaiser, MD
10:25 am – 10:30 am

Discussion

10:30 am – 10:40 am

Gene Therapy for Retinal Vascular Disease

  • Peter K. Kaiser, MD
10:40 am – 10:45 am

Discussion

10:45 am – 11:15 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

New Treatments for Age-related Macular Degeneration
  • Moderator: Peter K. Kaiser, MD
    Panelists: Caroline R. Baumal, MD; Allen C. Ho, MD; Daniel F. Martin, MD; David Sarraf, MD; Carl D. Regillo, MD, FACS; Christina Y. Weng, MD, MBA
11:15 am – 11:25 am

Complement Inhibition and Dry AMD

  • Peter K Kaiser, MD
11:25 am – 11:30 am

Discussion

11:35 am – 11:45 am

Neuroprotection, Oxidative Stress Reduction, and Toxic Byproduct Accumulation Reduction in Dry AMD

  • Peter K Kaiser, MD
11:45 am – 11:50 am

Discussion

11:50 am – 12:00 pm

HTRA1 Inhibition, Inflammasome Regulation, and Other Approaches in Dry AMD

  • Peter K Kaiser, MD
12:00 pm – 12:05 pm

Discussion

12:05 pm – 12:10 pm

Tyrosine Kinase Inhibition and Wet AMD

  • Peter K Kaiser, MD
12:10 pm – 12:15 pm

Discussio

12:15 pm – 12:30 pm

Break

CME LUNCH SEMINAR

12:30 pm – 1:30 pm

Lengthening the Treatment Interval in Age-related Macular Degeneration: Current Status and Insights

  • This activity is supported by an educational grant from Genentech, a member of the Roche Group

INDUSTRY WORKSHOPS**

2:00 pm – 4:00 pm

Practical Training in Equipment, Technology, and Insurance

  • This session is not approved for CME/CNE/COE Credit(s) and is neither provided by nor endorsed by Hawaiian Eye/Retina 2021 or their accredited provider.

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

  • Moderators: Sophie J. Bakri, MD; Caroline R. Baumal, MD

CME BREAKFAST SEMINAR

6:30 am – 7:30 am

Revelations in Retinal Vein Occlusion Management – What’s New?

  • This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
7:30 am – 7:45 am

Break

CME GENERAL SESSIONS

Macular Degeneration
  • Moderator: Rishi P. Singh, MD
7:45 am – 7:49 am

Announcements

  • Rishi P. Singh, MD
7:50 am – 8:06 am

The Role of Fluid in Exudative AMD

  • Nancy M. Holekamp, MD
8:07 am – 8:23 am

Sustained Delivery of Anti-VEGF Therapy for nAMD

  • Carl D. Regillo, MD, FACS
8:24 am – 8:40 am

Safety Update on Anti-VEGF Treatment

  • Roger A. Goldberg, MD, MBA
8:41 am – 8:57 am

Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD

  • Tarek S. Hassan, MD
8:58 am – 9:14 am

Sustained Delivery Devices in AMD

  • Caroline R. Baumal, MD
9:15 am – 9:45 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

9:45 am – 10:04 am

Non-neovascular AMD with Fluid: Exudation vs. Transudation in “Dry” AMD

  • David Sarraf, MD
10:05 am – 10:24 am

Update on Faricimab

  • Caroline R. Baumal, MD
10:25 am – 10:44 am

Gene and Cell Therapy Strategies for Neovascular and Atrophic AMD

  • Allen C. Ho, MD
10:45 am – 11:15 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

11:15 am – 12:15 pm

Panel Discussion

  • Moderator: Rishi P. Singh, MD
    Panelists: Caroline R. Baumal, MD; Roger A. Goldberg, MD, MBA; Tarek S. Hassan, MD; Nancy M. Holekamp, MD; Carl D. Regillo, MD, FACS
12:15 pm – 12:30 pm

Break

CME LUNCH SEMINAR

12:30 pm – 1:30 pm

Diabetic Macular Edema Management in 2021: What’s New?

  • This activity is supported by an educational grant from Allergan, Inc.

INDUSTRY WORKSHOPS**

2:00 pm – 4:00 pm

Practical Training in Equipment, Technology, and Insurance

  • This session is not approved for CME/CNE/COE Credit(s) and is neither provided by nor endorsed by Hawaiian Eye/Retina 2021 or their accredited provider.

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

  • Moderators: Allen C. Ho, MD; Peter K. Kaiser, MD

CME BREAKFAST SEMINAR

6:30 am – 7:30 am

Moving Diabetic Retinopathy Treatment Forward by Early Intervention to Improve Long-term Outcomes

  • This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
7:30 am – 7:45 am

Break

CME GENERAL SESSIONS

Diabetic Retinopathy and Retinal Vascular Disease
  • Moderator: Michael S. Ip, MD
7:45 am – 7:49 am

Announcements

  • Michael S. Ip, MD
7:50 am – 8:06 am

Classification and Treatment of Macular Telangiectasia: Update on Treatment

  • Roger A. Goldberg, MD, MBA
8:07 am – 8:23 am

Recognition of PAMM in Retinal Vascular Occlusions: Why Does it Matter?

  • David Sarraf, MD
8:24 am – 8:40 am

Top 5 Lessons Learned from the SCORE2 Study

  • Michael S. Ip, MD
8:41 am – 8:57 am

Organization of the Retinal Capillary Plexus and New Predictive Biomarkers in CRVO

  • David Sarraf, MD
8:58 am – 9:14 am

Diabetic Retinal Neurodegeneration: Should We Redefine Diabetic Retinopathy?

  • Elliott H. Sohn, MD
9:15 am – 9:45 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

9:45 am – 10:02 am

A Case-based Review of the Latest DRCR Retina Network Trials

  • Christina Y. Weng, MD, MBA
10:03 am – 10:20 am

Diabetic Retinopathy Regression: Disease Modification or Just a Pretty Picture

  • Roger A. Goldberg, MD, MBA
10:21 am – 10:44 am

When to Observe and When to Treat in DME: Applying Lessons from Clinical Trials

  • Yasha S. Modi, MD
10:45 am – 11:15 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

11:15 am – 11:30 am

Debate: Advanced NPDR Should be Treated with Anti-VEGF Therapy

  • Yes: Christina Y. Weng, MD, MBA
    No: Roger A. Goldberg, MD, MBA
    Rebuttal: Christina Y. Weng, MD, MBA
    Rebuttal: Roger A. Goldberg, MD, MBA
11:31 am – 12:15 pm

Panel Discussion: How I am Currently Managing My Retinal Vascular Disease Patients

  • Moderator: Michael S. Ip, MD
    Panelists: Roger A. Goldberg, MD, MBA; Yasha S. Modi, MD; David Sarraf, MD; Elliott H. Sohn, MD; Christina Y. Weng, MD, MBA
12:15 pm – 12:30 pm

Break

CME LUNCH SEMINAR

12:30 pm – 1:30 pm

The Tie2 Pathway: A New Approach in Retinal Disease?

  • This activity is supported by an educational grant from Genentech, a member of the Roche Group

INDUSTRY WORKSHOPS**

2:00 pm – 4:00 pm

Practical Training in Equipment, Technology, and Insurance

  • This session is not approved for CME/CNE/COE Credit(s) and is neither provided by nor endorsed by Hawaiian Eye/Retina 2021 or their accredited provider.

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

  • Moderators: Elliott H. Sohn, MD

INDUSTRY EXPERT THEATER BREAKFAST**

6:30 am – 7:30 am

Early Identification and Management Strategies for Patients With DME

  • Faculty: Nathan M. Radcliffe, MD; Inder Paul Singh, MD
    This promotional educational event is presented by Allergan, an AbbVie Company
  • ** This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2021 or its accredited provider.
7:30 am – 7:45 am

Break

CME GENERAL SESSIONS

Pediatric Retina, Uveitis and Tumors
  • Moderator: Caroline R. Baumal, MD
7:45 am – 7:49 am

Announcements

  • Audina M. Berrocal, MD
7:50 am – 8:06 am

The Aqueous Humor Liquid Biopsy for Retinoblastoma

  • Jesse L. Berry, MD
8:07 am – 8:23 am

Genetic Testing 101

  • Elliott H. Sohn, MD
8:24 am – 8:40 am

Rumors about Tumors: Top Do Not Miss Tips from an Ocular Oncologist

  • Jesse L. Berry, MD
8:41 am – 8:57 am

ROP: Where Are We Today

  • Eric D. Nudleman, MD, PhD
8:58 am – 9:14 am

Melanoma: Management in 2021

  • Jesse L. Berry, MD
9:15 am – 9:45 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

9:45 am – 10:04 am

Subretinal Gene Therapy and Surgical Lessons Learned

  • Christina Y. Weng, MD, MBA
10:05 am – 10:24 am

Pediatric Surgery What I Have Learned

  • Eric D. Nudleman, MD, PhD
10:25 am – 10:44 am

What I Have Learned from the COVID-19 Pandemic

  • Yasha S. Modi, MD
10:45 am – 11:15 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

11:15 am – 11:30 am

Infectious Retinitis

  • Debra A. Goldstein, MD
11:31 am – 11:46 am

Anti-VEGF in ROP

  • Eric D. Nudleman, MD, PhD
11:47 am – 12:14 pm

My Favorite Cases of 2020

  • Caroline R. Baumal, MD
12:15 pm – 12:30 pm

Break

CME LUNCH SEMINAR

12:30 pm – 1:30 pm

Therapeutic Targeting of the Complement System in Geography Atrophy

  • This activity is supported by an educational grant from Apellis

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

  • Moderators: Carl C. Awh, MD; Debra A. Goldstein, MD

BREAKFAST SEMINAR

6:30 am – 7:30 am

Educational Program & Breakfast

7:30 am – 7:45 am

Break

CME GENERAL SESSIONS

Surgery Update
  • Moderator: Carl D. Regillo, MD, FACS
7:45 am – 7:49 am

Announcements

  • Carl D. Regillo, MD, FACS
7:50 am – 8:06 am

Congenital Optic Nerve Anomalies Surgical Management

  • Caroline R. Baumal, MD
8:07 am – 8:23 am

Perfluorocarbon Liquids in Retinal Detachment Repair: Pearls and Pitfalls

  • Carl D. Regillo, MD, FACS
8:24 am – 8:40 am

Management of Challenging Macular Holes: A Conceptual Approach

  • Yasha S. Modi, MD
8:41 am – 8:57 am

New Innovations in Surgical Sterility

  • Tarek S. Hassan, MD
8:58 am – 9:14 am

Update on New Surgical Instruments

  • Caroline R. Baumal, MD
9:15 am – 9:45 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

9:45 am – 10:45 am

Interactive Panel: Vitreoretinal Surgical Pearls

  • Moderator: Carl D. Regillo, MD, FACS
    Panelists: Carl C. Awh, MD; Tarek S. Hassan, MD; Yasha S. Modi, MD; Christina Y. Weng, MD
10:45 am – 11:15 am

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

11:15 am – 12:15 pm

Best Cases of 2020

  • Moderator: Judy E. Kim, MD
    Panelists: Debra A. Goldstein, MD; David Sarraf, MD; Christina Y. Weng, MD, MBA; Roger A. Goldberg, MD, MBA
12:15 pm

Meeting Concludes